Pharmacy in Dundee, Scotland
We're a diversified biopharmaceutical firm committed to the discovery, development and commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders. Our strategy is focused on leading edge therapeutic management of cancer patients located on a portfolio of three medicines marketed by our ALIGN subsidiary and a deep development pipeline. We're concentrated on the discovery and development of orally-available anticancer agents that target the cell cycle with the objective of slowing the progression or shrinking the size of tumors, and enhancing the quality of life and improving survival rates of cancer patients.
From Our Website
read moreCyclacel's founding scientist, Professor Sir David Lane, a globally recognized authority in cell cycle biology, discovered p53, a key tumor suppressor gene that malfunctions in about two-thirds of human cancers. Cyclacel is using cell cycle control, transcriptional regulation and DNA damage response biology to develop innovative, targeted medicines for cancer and other proliferative diseases. Under Professor Lane's guidance, our drug discovery and development programs are focused on CDK2/9 isoforms, which operate as key components of the p53 pathway.
Career opportunities at Cyclacel
read moreWelcome to Cyclacel Pharmaceuticals' employment site and thank you for considering us as a potential employer. The Cyclacel Pharmaceuticals team is dedicated to meeting the company's goal - to develop novel, innovative medicines based on cancer cell biology for the treatment of cancer to enhance the quality of life and improve survival rates of cancer patients. The role: The Senior Manager/Associate Director, Clinical Data Management leads the data management of all studies in the portfolio. They are responsible for the performance of data management tasks from study start-up, inclusive of database design, through database lock for assigned projects within electronic data capture (EDC) systems.